Nuvation Bio Quarterly Cash Flow Statement
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.00+0.05 (+1.01%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nuvation Bio free cash flow
In the quarter ended Jun 30, 2026, Nuvation Bio generated -$43.0 million of operating cash flow. That left free cash flow of -$43.0 million, a free-cash-flow margin of -135.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Nuvation Bio cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -62.84M | 5.40M | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M | -19.65M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 536.00K | 536.00K | 539.00K | 534.00K | 356.00K | 310.00K | 219.00K | 162.00K | 244.00K | 58.00K | 55.00K | 55.00K |
| Stock-Based Compensation | 10.46M | 9.03M | 7.99M | 8.02M | 12.03M | 7.85M | 10.19M | 7.48M | 9.57M | 5.04M | 3.72M | 5.43M |
| Change in Working Capital | -1.18M | -6.01M | -1.03M | -4.11M | 9.70M | 7.56M | -11.31M | 10.71M | -8.67M | 1.74M | -2.23M | 2.10M |
| Operating Cash Flow | -42.97M | 5.07M | -29.73M | -52.89M | -48.18M | -42.63M | -46.30M | -31.09M | -37.32M | -15.70M | -15.03M | -16.16M |
| Capital Expenditures | — | — | 0 | — | — | — | 0 | — | — | — | — | — |
| Investing Cash Flow | 5.99M | -43.64M | 87.08M | -96.62M | 54.88M | 54.18M | 51.77M | 29.12M | 34.27M | 7.54M | 33.16M | -9.59M |
| Financing Cash Flow | 170.53M | 44.00K | 8.06M | 501.00K | 193.42M | 548.00K | -900.00K | -1.54M | 2.75M | 21.00K | 120.00K | 77.00K |
| Net Change in Cash | 133.21M | -38.70M | 65.19M | -149.07M | 199.99M | 12.25M | 5.69M | -4.25M | -225.00K | -8.14M | 18.25M | -25.67M |
| Free Cash Flow | -42.97M | 5.07M | -29.73M | -52.89M | -48.18M | -42.63M | -46.30M | -31.09M | -37.32M | -15.70M | -15.03M | -16.16M |
This table shows 12 quarterly periods of Nuvation Bio's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow NUVB's reporting calendar. What is a cash flow statement?